Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Original Research

1. Construction and Characterization of Recombinant HEK Cell Over Expressing α4 Integrin
Shamsi Naderi Beni, Shirin Kouhpayeh, Zahra Hejazi, Nahid Heidari Hafshejani, Hossein Khanahmad*
Adv Pharm Bull. 2015;5(3): 429-434. doi: 10.15171/apb.2015.058
PMCID: PMC4616894     PMID: 26504766     Scopus ID: 84983574230    
Article
PDF
XML
Cited By:
7
4
4
Research Article

2. Preparation and Statistical Modeling of Solid Lipid Nanoparticles of Dimethyl Fumarate for Better Management of Multiple Sclerosis
Smriti Ojha*, Babita Kumar
Adv Pharm Bull. 2018;8(2): 225-233. doi: 10.15171/apb.2018.027
PMCID: PMC6046417     PMID: 30023324     Scopus ID: 85048861588    
Article
PDF
XML
Cited By:
13
4
22
Research Article

3. Novel Doxorubicin Derivatives: Synthesis and Cytotoxicity Study in 2D and 3D in Vitro Models
Roman Akasov*, Maria Drozdova, Daria Zaytseva-Zotova, Maria Leko, Pavel Chelushkin, Annie Marc, Isabelle Chevalot, Sergey Burov, Natalia Klyachko, Thierry Vandamme, Elena Markvicheva
Adv Pharm Bull. 2017;7(4): 593-601. doi: 10.15171/apb.2017.071
PMCID: PMC5788214     PMID: 29399549     Scopus ID: 85043398199    
Article
PDF
XML
Cited By:
11
1
15
Review Article

4. A Review of Herbal Therapy in Multiple Sclerosis
Sina Mojaverrostami* ORCID, Maryam Nazm Bojnordi, Maryam Ghasemi-Kasman ORCID, Mohammad Ali Ebrahimzadeh ORCID, Hatef Ghasemi Hamidabadi ORCID
Adv Pharm Bull. 2018;8(4): 575-590. doi: 10.15171/apb.2018.066
PMCID: PMC6311642     PMID: 30607330     Scopus ID: 85057728103    
Article
PDF
XML
Cited By:
32
20
53
Research Article

5. Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis
Mehrdad Gholamzad ORCID, Hussein Baharlooi ORCID, Mehdi Shafiee Ardestani, Zeinab Seyedkhan, Maryam Azimi* ORCID
Adv Pharm Bull. 2021;11(3): 505-513. doi: 10.34172/apb.2021.058
PMCID: PMC8421634     PMID: 34513625     Scopus ID: 85108911841    
Article
PDF
Full Text
XML
Cited By:
3
1
12

Mini Review

6. Combination of Probiotics and Natural Compounds to Treat Multiple Sclerosis via Warburg Effect
Anjali Kandiruthi Ravi ORCID, Saradhadevi Kuppusami Muthukrishnan* ORCID
Adv Pharm Bull. 2022;12(3): 515-523. doi: 10.34172/apb.2022.057
PMCID: PMC9348531     PMID: 35935051     Scopus ID: 85140274831    
Article
PDF
Full Text
XML
Cited By:
0
0
5
Editorial

7. Multiplex NanoSPR Molecular Biosensor for Blood Cytokine Monitoring
Agha Zeeshan Mirza* ORCID
Adv Pharm Bull. 2022;12(3): 419-422. doi: 10.34172/apb.2022.046
PMCID: PMC9348532     PMID: 35935058     Scopus ID: 85140272847    
Article
PDF
Full Text
XML
Cited By:
0
0
0
Research Article

8. Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches
Ali Akbar Alizadeh ORCID, Behzad Jafari, Siavoush Dastmalchi* ORCID
Adv Pharm Bull. 2023;13(1): 113-122. doi: 10.34172/apb.2023.012
PMCID: PMC9871275     PMID: 36721815    
Article
PDF
Full Text
XML
Cited By:
0
2
Research Article

9. Overcoming Breast Cancer Drug Resistance: A Novel Approach Using siRNA-Mediated P-glycoprotein Downregulation to Enhance Vinorelbine Efficacy
Zahra Abbasfard ORCID, Abbas Behzad-Behbahani* ORCID, Banafshe Rastegari ORCID, Sirous Naeimi ORCID, Mehdi Moghanibashi ORCID, Fatemeh Safari ORCID
Adv Pharm Bull. 2024;14(2): 445-452. doi: 10.34172/apb.2024.030
PMCID: PMC11347736     PMID: 39206391    
Article
PDF
Full Text
XML
Cited By:
0